Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Johnson and Johnson
US Department of Justice
Chinese Patent Office
Cantor Fitzgerald
Dow
Fish and Richardson
Merck
Moodys

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078084

« Back to Dashboard

NDA 078084 describes METRONIDAZOLE IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare Corp, Hospira, and Mylan Labs Ltd, and is included in three NDAs. It is available from two suppliers. Additional details are available on the METRONIDAZOLE IN PLASTIC CONTAINER profile page.

The generic ingredient in METRONIDAZOLE IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 078084
Tradename:METRONIDAZOLE IN PLASTIC CONTAINER
Applicant:Baxter Hlthcare Corp
Ingredient:metronidazole
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 078084
Ingredient-typeNitroimidazoles
Medical Subject Heading (MeSH) Categories for 078084
Suppliers and Packaging for NDA: 078084
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 078084 ANDA Baxter Healthcare Corporation 36000-001 N 36000-001-24
METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 078084 ANDA Baxter Healthcare Corporation 36000-028 N 36000-028-24

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/100ML
Approval Date:Mar 31, 2008TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Express Scripts
Chinese Patent Office
Baxter
Harvard Business School
QuintilesIMS
AstraZeneca
Accenture
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.